LITH — Bioelife Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Bioelife, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.498 | -0.082 | -0.21 | -0.247 | -0.337 |
| Non-Cash Items | 0.421 | 0.009 | 0.09 | 0.096 | 0.234 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.041 | 0.039 | -0.01 | 0.029 | 0.027 |
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.037 | -0.033 | -0.129 | -0.122 | -0.076 |
| Capital Expenditures | — | — | -0.004 | 0 | -0.001 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.06 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | — | — | -0.004 | 0 | 0.06 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.033 | 0.035 | 0.14 | 0.115 | 0.02 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.004 | 0.001 | 0.006 | -0.007 | 0.004 |